Literature DB >> 2409285

Antibody responses in acute and chronic Q fever and in subjects vaccinated against Q fever.

D Worswick, B P Marmion.   

Abstract

An analysis is made of the antibody response to Coxiella burnettii Phase-1 and Phase-2 antigens, as measured by immunofluorescence in the IgM, IgG or IgA immunoglobulin classes, or by complement-fixation, in patients with acute and chronic Q fever and in vaccinated or skin-tested subjects. In acute (primary) Q fever, IgM specific antibodies to Phase-1 antigen are present in early convalescence together with IgM, IgG, IgA and CF antibodies to Phase-2 antigen. IgM specific antibody may persist for at least 678 days after onset of the acute illness. Patients with chronic Q fever have no IgM specific antibody to Phase-1 or -2 antigens, or only at very low levels; high levels of specific antibody in the IgG and IgA classes, together with CF antibody to both antigenic phases, appear to be characteristic. The serological response in initially seronegative, vaccinated subjects is mainly to Phase-1 antigen in the IgM fraction, and to a lesser degree to Phase-2 antigen by CF and in IgM and IgG classes. Subjects who were equivocally seropositive before vaccination showed IgA and IgG specific antibody responses to Phase-1 antigen and CF and IgG class responses to Phase-2 antigen. Similar antibody profiles were observed in patients who seroconverted after a positive skin-test. Data are also presented on the suitability of C. burnettii antigens for use in immunofluorescence and on the binding of IgM specific antibody by Phase-1 antigen but its failure to fix complement.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409285     DOI: 10.1099/00222615-19-3-281

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  21 in total

1.  Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens.

Authors:  A A Izzo; B P Marmion; T Hackstadt
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  Q fever pneumonia in children in Japan.

Authors:  H To; N Kako; G Q Zhang; H Otsuka; M Ogawa; O Ochiai; S V Nguyen; T Yamaguchi; H Fukushi; N Nagaoka; M Akiyama; K Amano; K Hirai
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Q fever seroprevalence in metropolitan samples is similar to rural/remote samples in Queensland, Australia.

Authors:  S J Tozer; S B Lambert; T P Sloots; M D Nissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-16       Impact factor: 3.267

4.  Seroprevalence to Coxiella burnetii among residents of the Hunter New England region of New South Wales, Australia.

Authors:  Aminul Islam; John Ferguson; Rod Givney; Stephen Graves
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

5.  Rapid method for detection of Coxiella burnetii antibodies using high-density particle agglutination.

Authors:  S V Nguyen; H Otsuka; G Q Zhang; H To; T Yamaguchi; H Fukushi; A Noma; K Hirai
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

6.  Combined determination of Coxiella burnetii-specific immunoglobulin M (IgM) and IgA improves specificity in the diagnosis of acute Q fever.

Authors:  P Devine; C Doyle; G Lambkin
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

7.  Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-12-23       Impact factor: 3.747

8.  Serology in chronic Q fever is still surrounded by question marks.

Authors:  M C A Wegdam-Blans; H T Tjhie; J M Korbeeck; M N Nabuurs-Franssen; L M Kampschreur; T Sprong; J A W Teijink; M P Koopmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-16       Impact factor: 3.267

9.  Evaluation of a novel commercial enzyme-linked immunosorbent assay detecting Coxiella burnetii-specific immunoglobulin G for Q fever prevaccination screening and diagnosis.

Authors:  Peter R Field; Avelina Santiago; Sau-Wan Chan; Dhara B Patel; David Dickeson; Jody L Mitchell; Peter L Devine; Alan M Murphy
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

Review 10.  Q fever.

Authors:  L G Reimer
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.